Home › NDC Lookup › Ingredients › Lidocaine - 4% › 63135-0312-13
TOPICAINE LIDOCAINE 4% 4 g/100g Gel — NDC 63135-0312-13 package photo

TOPICAINE LIDOCAINE 4% 4 g/100g Gel

by ESBA LABORATORIES INC. · 1 TUBE in 1 BOX (63135-312-13) / 10 g in 1 TUBE
NDC 63135-0312-13
🏷️ FDA NDC (as labeled) 63135-312-13 billing pads the product segment with a zero
This package
Contains10 g in 1 tube Pack sizes3 compare ↓
Also comes in: 30 g 63135-0312-30 113 g 63135-0312-04
OTC Discontinued Non-controlled ⚠ Discontinued by firm
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Jun 2015. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

🆔 Identity & classification

FDA NDC (as labeled) 63135-312-13
Product NDC 63135-312
11-digit billing NDC 63135031213
NCPDP billing unit GM — per gram (weight)
RxCUI 1291672, 1651001
UNII 98PI200987
UPC 0363135312135
Application # M017
SPL Set ID 7f96e980-891e-743d-e053-2a91aa0aea5f
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Local Anesthesia
Chemical class Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Jun 2015)
Marketing start 2003-04-20
Route TOPICAL
Dosage form GEL
Substance LIDOCAINE
GPI-14 90850060004015
GPI class Topicaine
GCN Seq No 068687
GCN 31517
HICL code 010705
Ingredient (HICL) Lidocaine
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5H
Therapeutic class — specific (HIC3) Topical Local Anesthetics
AHFS code 72:00.00.00
AHFS class Local Anesthetics
FDB label name TOPICAINE 4% GEL
FDB brand name Topicaine
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 63135-312-13 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 63135-0312-13. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Antiarrhythmic class.

Pharmacologic class Antiarrhythmic, Amide Local Anesthetic
Drug family (ATC) Antiarrhythmics, class Ib, Local anesthetics, Anesthetics for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerESBA LABORATORIES INC.
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code63135
First marketedApr 2003
Product typeHuman Otc Drug
Portfolio5 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name TOPICAINE 4% GEL Ingredient Lidocaine
📗 Our plain-language guide HelloPharmacist
  • It's best to avoid using two lidocaine products at the same time unless your doctor says it's okay. When you use multiple products containing a local anesthetic, the total amount a...
  • Can I use a lidocaine patch and a lidocaine cream at the same time?
  • No — please don't do this. Heat significantly increases how much lidocaine is absorbed through your skin, which can push drug levels in your blood higher than they should be. Stick...
  • Can I put a heating pad on the area where I applied a lidocaine patch?
📖 Read our full Lidocaine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • 36.842 g / 100 g UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • 2.5 g / 100 g UNII ZY81Z83H0X
    Aloe vera leaf is a plant extract derived from the aloe plant. It is used in medicines as a natural moisturizer and skin-soothing agent in topical formulations.
  • 2 g / 100 g UNII LKG8494WBH
    Benzyl alcohol is a clear liquid used as a preservative and solvent in medicines. It helps prevent bacterial and fungal growth and dissolves other ingredients to create uniform liquid formulations.
  • 0.6 g / 100 g UNII 4Q93RCW27E
    A synthetic polymer made from acrylic acid that's crosslinked for stability. It acts as a thickener and gelling agent in creams and gels, helping the medicine spread evenly and maintain its texture.
  • 0.024 g / 100 g UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • 5 g / 100 g UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • 2 g / 100 g UNII Y98611C087
    Glyceryl laurate is an emulsifier made by combining glycerin and lauric acid. It helps mix oil and water-based ingredients together in the medicine and may improve how the product feels or spreads.
  • 2.5 g / 100 g UNII 724GKU717M
    Jojoba oil is a natural liquid wax extracted from jojoba plant seeds. It's used in medicines as an emollient and lubricant to soften and smooth the product, and sometimes as a carrier or penetration enhancer.
  • 44.534 g / 100 g UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAloe Barbadensis Leaf Extract, Benzyl Alcohol, Carbomer, Disodium EDTA, Glycerin, Glyceryl Laurate, SD Alcohol 40B, Simmondsia Chinensis (Jojoba) Seed Oil, Water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 30 g 113 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Rugby Lidocaine 4 g/100g 00536-1357-95 Rugby 1 tube $0.428 — Availability likely —
Lidocaine 4% Topical Anesthetic Cream 4 g/100g 83720-0523-01 Oncor 1 tube $0.490 — Availability likely —
Zcaine Fast Acting Anesthetic 4 g/100g 27789-0911-02 PHI, 60 g — — FDA listed —
Plum Smooth Plumb Numb Gelee 4 g/100g 49911-0884-01 Universal 28.35 g — — FDA listed —
Hush Anesthetic 40 mg/g 49947-0002-02 HUSH 56.7 g — — FDA listed —
Sonacaine Topical Anesthetic With Menthol 4 g/100g 62221-0935-02 Filltech 60 g — — FDA listed —
Topicaine 4 g/100gthis 63135-0312-13 ESBA 1 tube — — Discontinued —
Comfortcaine 40 mg/g 65008-0005-04 QS 1 bottle — — FDA listed —
Greencaine Blast 40 mg/g 69747-0040-01 ALMA 113 g — — FDA listed —
Bed Bug Instant Bite Relief 40 mg/g 70466-0001-01 P.F. 1 tube — — FDA listed —
Lidocaine 4 g/100mL 71888-0102-02 Bellus 12 packets — — FDA listed —
Hunter Beach 4% 4 g/100mL 82517-0002-04 HUNTERS 118 ml — — FDA listed —
Hempvana Ultra Strength Pain Relief Cream 4 g/100g 73287-0016-01 Telebrands 1 jar — — FDA listed —
Numbsure LIDOCAINE 4 g/100g 83714-0003-01 Hambli 1 tube — — FDA listed —
Lidocaine 4 g/100g 42291-0399-30 AvKARE 1 tube — — FDA listed —
Hempvana Ultra Strength Pain Relief Cream Platinum 4% Lidocaine 4 g/100g 73287-0042-01 Telebrands 1 jar — — FDA listed —
RelaxInk LIDOCAINE 4 g/100g 83714-0004-01 Hambli 1 tube — — FDA listed —
Anecream 4 g/100g 24357-0701-06 Focus 5 tubes — — FDA listed —
Swiftalyn Numbing Cream 4 g/100g 87013-0002-01 GENUINE 50 g — — FDA listed —
Lubricaine 4 g/100g 63135-0727-04 ESBA 113 g — — FDA listed —
Numbing Pain Relief 4 g/100g 00363-6261-07 Walgreen 1 applicator — — FDA listed —
Recovery Numb 4 g/100g 49436-0099-30 PURKLENZ 30 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2003
On the market since
Apr 2003
📍
2026
Currently FDA-listed
23 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for TOPICAINE (this brand).

Top reported reactions

Nausea33
Pain26
Headache23
Vomiting19
Dizziness18
Hypotension18
Fatigue15

Age at onset

Infant1
Adult21
Elderly9

Reporter sex

436 reports
Male · 45%
Female · 54%
Unknown · 1%

Serious outcomes

Hospitalization137
Life-threatening53
Disabling21
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 32 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
63135-0312-04 113 g in 1 TUBE (63135-312-04) 2003-04-20 Discontinued by firm
63135-0312-13 You're viewing this 1 TUBE in 1 BOX (63135-312-13) / 10 g in 1 TUBE 2003-04-20 Discontinued by firm
63135-0312-30 1 TUBE in 1 BOX (63135-312-30) / 30 g in 1 TUBE 2003-04-20 Discontinued by firm

Pack size FAQ

What quantity is in NDC 63135-0312-13?
NDC 63135-0312-13 is listed by the FDA — 1 tube in 1 box / 10 g in 1 tube.
What NDC number is used to bill for this package of TOPICAINE LIDOCAINE 4% 4 g/100g Gel?
Bill NDC 63135-0312-13 — the 11-digit billing format is 63135031213. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 63135-312-13, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 63135-0312-13, written without dashes as 63135031213. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 63135-0312-13, the first segment (63135) is the labeler code FDA assigned to ESBA LABORATORIES INC.; the middle segment (0312) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (13) identifies this exact package size and type. Together they name one specific package of one specific product.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 1 tube (63135-0312-30), 113 g (63135-0312-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
ESBA LABORATORIES INC. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 7 words ▾

Uses For the temporary relief of pain.

⏱️ Dosage and Administration 23 words ▾

Directions Apply externally to affected area up to 3 to 4 times a day. Children under 2 years of age consult a doctor.

⚠️ Warnings 20 words ▾

Warnings For external use only Flammable Keep away from sparks, heat and fire. Cap tube tightly when not in use.

🧪 Active Ingredient 5 words ▾

Active ingredient Lidocaine 4% w/w

🧪 Inactive Ingredients 23 words ▾

Inactive Ingredients Aloe Barbadensis Leaf Extract, Benzyl Alcohol, Carbomer, Disodium EDTA, Glycerin, Glyceryl Laurate, SD Alcohol 40B, Simmondsia Chinensis (Jojoba) Seed Oil, Water

🎯 Purpose 3 words ▾

Purpose Topical Anesthetic

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 63127-0101-01 · Luzern 63135-0581-04 · ESBA →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.